| DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine) - BioAssay Summary DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine) ..more |
_ | |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Target Sequence: RecName: Full=Histamine H2 receptor; Short=H2R; Short=HH2R; AltName: Full=Gastric receptor I Description .. ![]() Comment .. ![]() Gene:HRH2 Conserved Domain Related Protein 3D Structures BioActive Compounds: 43 Description: DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine) Comment Compounds with activity <= 50uM or explicitly reported as active by ChEMBL are flagged as active in this PubChem assay presentation. Publication: Journal: NULL Year: NULL Volume: NULL Issue: NULL First Page: NULL Last Page: NULL Categorized Comment ChEMBL Assay Type: Binding ChEMBL Assay Data Source: DrugMatrix in vitro pharmacology assays ChEMBL Assay Test Type: In vitro ChEMBL Assay Cell Type: CHO-K1 ChEMBL Assay Subcellular Fraction: membranes ChEMBL Target ID: 102 ChEMBL target type: Target is a single protein chain Result Definitions
* Activity Concentration. Data Table (Concise) Classification
PageFrom: |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||